Effects of concurrent Omega-3 and Cranberry juice consumption on eradication of Helicobacter pylori, gastrointestinal symptoms, some serum inflammatory and oxidative stress markers in adults with Helicobacter pylori infectio

Phase 2

Recruiting

• Conditions: Helicobacter pylori.; Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters; B98.0

• Registration Number: IRCT20151128025274N3
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

Age 18 to 65 years old
Helicobacter pylori infection
Gastrointestinal complaints
Body mass index 18.5 to 35 kg / m2

Exclusion Criteria

Having a history of drug therapy to eradicate Helicobacter pylori infection
Stomach surgery
History of peptic ulcer and gastrointestinal malignancies
Having any disease that causes inflammation and increased levels of inflammatory markers, such as diabetes, cardiovascular disease, respiratory infections such as asthma and ...
Getting immunodeficiency diseases
Developing chronic diseases requiring drug treatment
Taking medications other than prescription drugs
Receiving antibiotics or proton pump inhibitors or H2 blockers over the past 2 months
Taking omega supplementation At least 3 months before the start of the study
Use of any diet supplements During the study 3 months before the start of the study
Changes in the diet during the study period
Consumption of less than 80% of the supplements delivered to the patient during the study period.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
egative cases of Helicobacter pylori infection. Timepoint: Three weeks after the end of treatment. Method of measurement: Checking of H.Pylori stool antigen.;Scale of gastrointestinal complaints questionnaire from Helicobacter pylori infection. Timepoint: Before and at the end of the study. Method of measurement: Questionnaire.;Serum levels of Il-17, TGFß1 and INF-?. Timepoint: Before and at the end of the study. Method of measurement: ELISA method.;Serum levels of TAC and MDA. Timepoint: Before and after study. Method of measurement: ELISA method.